{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1235.350",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate": "2023-08-08"
  } ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.350",
  "identifier": [ {
    "system": "urn:ietf:rfc:3986",
    "value": "urn:oid:2.16.840.1.113762.1.4.1235.350"
  } ],
  "version": "20230808",
  "name": "COVID19Vaccine_EventClinicalGrouping",
  "title": "COVID19 Vaccine_Event Clinical Grouping",
  "status": "active",
  "date": "2023-08-08T01:00:54-04:00",
  "publisher": "B.well Connected Health Steward",
  "expansion": {
    "identifier": "urn:uuid:8f87a57c-8632-4d92-873b-216a565bae64",
    "timestamp": "2024-02-17T12:31:10-05:00",
    "total": 28,
    "offset": 0,
    "parameter": [ {
      "name": "count",
      "valueInteger": 1000
    }, {
      "name": "offset",
      "valueInteger": 0
    } ],
    "contains": [ {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "207",
      "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "208",
      "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "210",
      "display": "SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "211",
      "display": "SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "212",
      "display": "SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "217",
      "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "218",
      "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "219",
      "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "221",
      "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "227",
      "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "228",
      "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "229",
      "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "230",
      "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "01022024",
      "code": "2468235",
      "display": "SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "01022024",
      "code": "2470234",
      "display": "SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML Injectable Suspension"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "01022024",
      "code": "2479835",
      "display": "SARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML Injectable Suspension"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "300",
      "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "301",
      "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "302",
      "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "502",
      "display": "SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "506",
      "display": "SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "510",
      "display": "SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "511",
      "display": "SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "518",
      "display": "SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "519",
      "display": "SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna"
    }, {
      "system": "http://hl7.org/fhir/sid/cvx",
      "version": "20231214",
      "code": "520",
      "display": "SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "91304",
      "display": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, 5 mcg/0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
      "version": "2024",
      "code": "91304",
      "display": "Severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use"
    } ]
  }
}